I-CANVAX 2024: Innovative Cancer Vaccine Development

Global and Indian Synergies

December 12, 2024

Kolkata, India

 

 

 

 

Dr. John T. Schiller, PhD

Distinguished Investigator, National Cancer Institute

Dr. John Schiller is a world-renowned expert in virus-related cancers and the development of the the human papillomavirus (HPV) prophylactic vaccines that ultimately became the commercial vaccines Cervarix and Gardasil.  His groundbreaking research at the National Cancer Institute has had a profound impact on cancer prevention, leading to the development of life-saving vaccines.

https://ccr.cancer.gov/staff-directory/john-t-schiller

 

Dr. Elad Sharon, MD, MPH

Senior Investigator, Harvard Medical School

Dr. Elad Sharon is a Senior Investigator at Harvard Medical School, where his work focuses on the clinical development of novel cancer therapies and immunotherapy. With a deep expertise in oncology, Dr. Sharon plays a pivotal role in advancing clinical trials and shaping the direction of cutting-edge cancer treatment strategies.

https://connects.catalyst.harvard.edu/Profiles/display/Person/64613

 

Dr. Chandan Guha, MBBS, PhD

Vice Chair and Professor, Department of Radiation Oncology, Albert Einstein College of Medicine

Dr. Chandan Guha is a renowned leader in radiation oncology and oncophysics, with extensive expertise in radiation-induced immune modulation and innovative cancer treatments. As the Director of the Einstein Institute of Oncophysics, Dr. Guha’s research focuses on integrating radiotherapy with immunotherapy to improve treatment outcomes for cancer patients.

https://einsteinmed.edu/faculty/7020/chandan-guha

 

Dr. Vivek Mittal, PhD

Professor of Cell and Developmental Biology in Radiation Oncology, Weill Cornell Medicine

Dr. Vivek Mittal is a distinguished researcher specializing in tumor microenvironment and cancer immunotherapy. His work at Weill Cornell Medicine explores how the microenvironment influences cancer progression and response to therapies, with a focus on integrating immune-based approaches with radiation therapy to improve cancer treatment outcomes.

https://vivo.weill.cornell.edu/display/cwid-vim2010

 

Dr. Angelika Riemer, PhD

Head of Cancer Immunoprevention, German Cancer Research Center (DKFZ)

Dr. Angelika Riemer is at the forefront of cancer immunoprevention research, particularly in the development of vaccines to prevent virus-induced cancers. Her work at DKFZ focuses on HPV-related cancer prevention, contributing significantly to global efforts in cancer immunotherapy.

https://www.dzif.de/en/angelika-riemer

 

Dr. Partha Basu, MD, PhD

Head, Screening Group, International Agency for Research on Cancer (IARC), France

Dr. Partha Basu is a leading global expert in cancer prevention, with a focus on cervical cancer screening and early detection in low-resource settings. His work at IARC is instrumental in developing and implementing large-scale cancer screening programs aimed at reducing the global cancer burden.

https://www.linkedin.com/in/partha-basu-ba169773

 

Dr. Thangarajan Rajkumar, MD, PhD

Senior Consultant, Molecular Oncology, Cancer Institute (WIA), Chennai, India

Dr. Thangarajan Rajkumar is a pioneer in molecular oncology and cancer genomics. He has made significant contributions to personalized cancer treatment, particularly in India, and continues to advance research in the molecular mechanisms of cancer and innovative therapeutic approaches.

https://www.alumnimmc.com/halloffame/dr-thangarajan-rajkumar/25

 

Dr. Sachet Shukla, PhD

Assistant Professor, Department of Genitourinary Medical Oncology, MD Anderson Cancer Center

Dr. Sachet Shukla specializes in the molecular biology of genitourinary cancers, focusing on prostate and bladder cancers. His research at MD Anderson Cancer Center aims to understand the molecular mechanisms of tumor resistance and to develop new therapeutic strategies for these cancers.

https://faculty.mdanderson.org/profiles/sachet_shukla.html

 

Dr. Anupama Goyal, PhD

Senior Scientist

Dr. Anupama Goyal is a Senior Scientist with expertise in pharmaceutical research, specializing in developing novel drug delivery systems and advanced therapies. With years of experience in research and development, she has made significant contributions to the pharmaceutical industry, focusing on improving therapeutic outcomes through innovative approaches.

https://www.linkedin.com/in/anupama-goyal-1955987b

 


For any queries, please send email to info.care@tcgcrest.org